TissueTech™, Inc. is pioneering the field of regenerative medicine through our superior platform technology, cutting edge scientific innovation, and commitment to commercial excellence. The Company markets innovative amniotic and umbilical cord-based products used by physicians around the world in eye care, wound care, and orthopedics. TissueTech’s proprietary technology is clinically proven to promote regenerative healing. Learn More
Leader in Regenerative Medicine
With more than 30 years of developmental research partially funded by the National Institute of Health, our Company was the first to commercialize the clinical application of human amniotic membrane and umbilical cord.
Learn More
Proprietary Technology
Our proprietary CryoTek™ technology preserves the innate anti-inflammatory, anti-scarring and regenerative healing properties of amniotic membrane and umbilical cord for transplantation.
Learn More
Innovative Therapies & Products
Our innovative products for use in eye care, wound care and orthopedics are provided through our commercial subsidiaries, Bio-Tissue®, Inc. and Amniox® Medical, Inc.
Visit Biotissue.com | Visit AmnioxMedical.com